The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Patty P.A. Dhooge, Philipp T. Möller, Camiel J.F. Boon, Andrew J. Lotery, Philipp Herrmann, Maurizio Battaglia Parodi, Wolfgang Klein, Mario G. Fsadni, Thomas H. Wheeler-Schilling, Oliver Jungmann, Hans Müller, Frank G. Holz, Steffen Schmitz-Valckenberg, Tobias M. Peters, Katarina Stingl,15, Carel B. Hoyng, Soraprazan Consortium

Journal title: Open Research Europe

Journal publisher: European Commission

Published year: 2021

DOI identifier: 10.12688/openreseurope.13872.1

ISSN: 2732-5121